Skip to main content
. 2017 Dec 6;37(2):363–369. doi: 10.1007/s10096-017-3144-z

Table 1.

Co-pathogen detection in human coronavirus-positive patients

Co-pathogena HCoV (n = 231) 229E (n = 38) OC43 (n = 161) NL63 (n = 33) HKU1 (n = 19)
Flu A 50 (21.6) 7 (18.4) 38 (23.6) 4 (12.1) 4 (21.1)
RSV 50 (21.6) 10 (26.3) 29 (18.0) 10 (30.3) 3 (15.8)
MP 39 (16.9) 3 (7.9) 27 (16.8) 3 (9.1) 8 (42.1)
HPIV 33 (14.3) 5 (13.2) 27 (16.7) 2 (6.1) 1 (5.3)
ADV 22 (9.5) 3 (7.9) 14 (8.7) 5 (15.2) 2 (10.5)
EV 20 (8.6) 4 (10.5) 10 (6.2) 6 (18.2) 1 (5.3)
HBoV 15 (6.5) c 9 (5.6) 3 (9.1) 3 (15.8)
HMPV 15 (6.4) 3 (7.9) 14 (8.7) 1 (3.0)
HRV 13 (5.6) 2 (5.3) 10 (6.2) 1 (3.0)
Flu B 10 (4.3) 9 (5.6) 1 (5.3)
CP 4 (1.7) 3 (1.9) 1 (3.0)
HCoVb 18 (7.8) 15 (39.5) 16 (9.9) 4 (12.1) 2 (10.5)
229E 15 (9.3) 2 (6.1)
OC43 15 (39.5) 2 (6.1) 1 (5.2)
NL63 2 (5.2) 2 (1.2) 1 (5.2)
HKU1 1 (0.6) 1 (3)

Data are presented as no. (%) of each group. Percentages sum to over 100% because some patients had more than one diagnosis

aFlu A, influenza A virus; Flu B, influenza B virus; ADV, adenovirus; HRV, human rhinovirus; HMPV, human metapneumovirus; EV, enterovirus; MP, Mycoplasma pneumoniae; RSV, respiratory syncytial virus; HBoV, human bocavirus; HPIV, human parainfluenza virus; CP, Chlamydia pneumoniae; HCoV, human coronavirus

bDetection of more than one strain of HCoV

cNot detected